X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ORCHID PHARMA LTD - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD ORCHID PHARMA LTD ALEMBIC LTD/
ORCHID PHARMA LTD
 
P/E (TTM) x 55.4 0.2 28,503.2% View Chart
P/BV x 3.1 0.2 1,358.2% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 ALEMBIC LTD   ORCHID PHARMA LTD
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
ORCHID PHARMA LTD
Sep-13
ALEMBIC LTD/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs53194 27.2%   
Low Rs2935 83.7%   
Sales per share (Unadj.) Rs4.7276.5 1.7%  
Earnings per share (Unadj.) Rs8.8-79.2 -11.1%  
Cash flow per share (Unadj.) Rs9.0-43.5 -20.7%  
Dividends per share (Unadj.) Rs0.150-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs27.753.9 51.4%  
Shares outstanding (eoy) m267.0370.45 379.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x8.70.4 2,100.1%   
Avg P/E ratio x4.7-1.4 -323.7%  
P/CF ratio (eoy) x4.6-2.6 -173.0%  
Price / Book Value ratio x1.52.1 69.7%  
Dividend payout %1.70-   
Avg Mkt Cap Rs m10,9628,067 135.9%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m2382,527 9.4%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m1,26019,477 6.5%  
Other income Rs m264407 64.8%   
Total revenues Rs m1,52419,884 7.7%   
Gross profit Rs m831,103 7.5%  
Depreciation Rs m612,519 2.4%   
Interest Rs m05,227 0.0%   
Profit before tax Rs m285-6,236 -4.6%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-32511 -6.3%   
Tax Rs m6-125 -4.9%   
Profit after tax Rs m2,343-5,580 -42.0%  
Gross profit margin %6.65.7 116.1%  
Effective tax rate %2.12.0 106.6%   
Net profit margin %185.9-28.7 -648.8%  
BALANCE SHEET DATA
Current assets Rs m1,68911,014 15.3%   
Current liabilities Rs m48632,060 1.5%   
Net working cap to sales %95.4-108.1 -88.3%  
Current ratio x3.50.3 1,011.1%  
Inventory Days Days21795 228.7%  
Debtors Days Days8134 241.5%  
Net fixed assets Rs m1,62429,440 5.5%   
Share capital Rs m534705 75.8%   
"Free" reserves Rs m5,9602,043 291.8%   
Net worth Rs m7,4043,800 194.8%   
Long term debt Rs m1049,018 1.2%   
Total assets Rs m8,01046,510 17.2%  
Interest coverage x950.7-0.2 -492,267.1%   
Debt to equity ratio x02.4 0.6%  
Sales to assets ratio x0.20.4 37.6%   
Return on assets %29.3-0.8 -3,848.6%  
Return on equity %31.6-146.9 -21.5%  
Return on capital %31.3-3.7 -837.8%  
Exports to sales %2.937.9 7.8%   
Imports to sales %28.922.6 127.6%   
Exports (fob) Rs m377,378 0.5%   
Imports (cif) Rs m3644,406 8.3%   
Fx inflow Rs m377,513 0.5%   
Fx outflow Rs m3655,649 6.5%   
Net fx Rs m-3281,865 -17.6%   
CASH FLOW
From Operations Rs m3461,682 20.6%  
From Investments Rs m-48-9,860 0.5%  
From Financial Activity Rs m-3016,644 -4.5%  
Net Cashflow Rs m-3-1,535 0.2%  

Share Holding

Indian Promoters % 64.0 32.3 198.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 4.6 4.3%  
FIIs % 9.7 3.3 293.9%  
ADR/GDR % 0.0 4.6 -  
Free float % 26.1 55.3 47.2%  
Shareholders   54,701 84,811 64.5%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   PIRAMAL ENTERPRISES  GSK PHARMA  DR. DATSONS LABS  DR. REDDYS LAB  NOVARTIS  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Analysis of IPOs Launched in 2018, Governments Effort to Boost Aviation Infrastructure and Key Stocks in Action Today(Pre-Open)

The returns from initial public offers (IPOs) launched in 2018 are mixed. Comparing the gain/ (loss) since the listing date as mentioned in the last column, seven stocks are in the negative territory.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jun 21, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS